Product & Tech Executive | Adjunct Prof | Advisor | MedTech | CleanTech | Imaging | AI | Analytics
“𝐌𝐚𝐫𝐤𝐞𝐭 𝐕𝐚𝐥𝐮𝐞 𝐏𝐞𝐫 𝐄𝐦𝐩𝐥𝐨𝐲𝐞𝐞” 𝐨𝐟 𝐏𝐡𝐚𝐫𝐦𝐚 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 I previously wrote about top pharma companies by market #value. I also wrote about the total number of their #employees. Here is a look at the same companies when you normalize their market value by their number of employees, yielding a "market value per employee" metric. A company that generates greater value and wealth with fewer employees is generally considered more appealing to investors and even employees. Today, the following companies have the highest market value per employee in #pharma and #biotech industry 1- argenx 2- Vertex Pharmaceuticals 3- Eli Lilly and Company 4- Revolution Medicines 5- Regeneron 6- Ascendis Pharma 7- Genmab 8- Ionis Pharmaceuticals, Inc. 9- AbbVie 10- Amgen 11- Novo Nordisk 12- Zoetis 13- Moderna 14- Gilead Sciences * Views and ideas are my own. The information that I provide is public and intended to be educational only and is not endorsement or financial advice. I always encourage the readers to do their research.
My previous post on market value per employee for medical companies https://www.linkedin.com/posts/rezazahiri_medtech-valuation-marketcap-activity-7219402841956700162-_fsH?utm_source=share&utm_medium=member_desktop
My previous post on most valued pharma companies https://www.linkedin.com/posts/rezazahiri_pharmaceutical-pharma-marketcap-activity-7218653090852311041-IhML?utm_source=share&utm_medium=member_desktop
Hmmm, another perspective could be the higher ranking ones stretch their employees out thinner… some companies may not be as labour-efficient as the top companies in this list but employees could end up with a better work life balance? Interesting comparison nonetheless, just wondering the reasons behind it.
Le Minh Thong
2mo
Wonderful but I wonder why IQVIA is in this list?
This is such a manipulated statistic. Some departments are 50% contractors in order to change it. Which ends up costing the company more because of high turnover of the contractors, employees with no investment in the company’s future, and the unhappiness of the underpaid under insured contractors.
Pedro Cuisinier
2mo
Where is thermofisher?
Mike Petrillo
2mo
Very informative Reza Zahiri, PhD, MBA Do you have a similar chart for med dev?
Great visual. Also, it would be nice to understand what defines an employee. If it is just full time employees only. Then the hidden secret sauce could be that these top companies may engage in high counts of contingent or contract workers to get work done. Also, they could be getting work done by 3rd parties on SOW work. If these hidden costs are not taken into account, this great visual should have a second version showing contractor hours to be more meaningful.
Fabrice G.
2mo
Reza Zahiri, PhD, MBA Another relevant metric could be the ROI per employee. While the current method may not be applicable, a more accurate approach might be calculating Total Revenue / Total Staff Cost. This would allow for better comparison between companies operating in different regions with varying minimum wage levels (if applicable).
Product & Tech Executive | Adjunct Prof | Advisor | MedTech | CleanTech | Imaging | AI | Analytics
2moMy previous post on biggest pharma employers https://www.linkedin.com/posts/rezazahiri_medtech-pharma-pharmaceutical-activity-7226646637127852032-htbf?utm_source=share&utm_medium=member_desktop